About Us
Overview
Our Leadership
History
Subsidiaries
Vision
ESH
Our Science
Platform Technology
Spore Biologics
Our Pipeline
Pipeline
SAB
Our Products
Industrial Special Enzymes
Bio-Health Care Ingredients
IR/PR
IR Notice
News & Events
Stock Price Information
PR Center
Contact Us
Notice
Careers
Online Inquiry
Location
KR
EN
GF Mall
in
메뉴닫기
KR
EN
GF HealthMall
in
About Us
Overview
Our Leadership
History
Subsidiaries
Vision
ESH
Our Science
Platform Technology
Spore Biologics
Our Pipeline
Pipeline
SAB
Our Products
Industrial Special Enzymes
Bio-Health Care Ingredients
IR/PR
IR Notice
News & Events
Stock Price Information
PR Center
Contact Us
Notice
Careers
Online Inquiry
Location
메뉴보기
Our Pipeline
Pipeline
SAB
SAB
메뉴열기
Pipeline
SAB
Scientific Advisory Board
C. Chiquet
Professor at COUF University in France
Ophthalmologist at Grenoble University Hospital, France
Ocular disease therapeutics development and clinical trial expert
Clinical trial experience with SOD for treatment of wetAMD
Prof. Jeong-Hun Kim
Professor at Seoul National University in Biomedical Science
Ophthalmologist at Seoul National University Hospital
Inborn ocular disease therapeutics development using gene editing technology
Dr. Won-Bae Kim
Doctoral degree at Seoul National University in Pharmacy
Dong-A ST CEO, vice-president.
Member of KAST (The Korean Academy of Science and Technology)
Partners
US FDA IND filing preparation with US clinical trials and licensing specialist KCRN
US FDA IND filing scheduled for wet AMD treatment
KFDA IND filing scheduled for IBD treatment